QURE News

Pomerantz LLP Calls Attention to Class Action Involving uniQure N.V. – QURE

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages uniQure N.V. Investors to Secure Counsel Before Important Deadline in Securities Class Action - QURE

QURE Investors Have Opportunity to Lead uniQure N.V. Securities Fraud Lawsuit

Pomerantz LLP Alerts Shareholders to Investor Suit Filed Against uniQure N.V. – QURE

QURE INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that uniQure N.V. Investors with Losses Have Opportunity to Lead Class Action Lawsuit!

uniQure N.V. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - QURE

QURE Investors Have Opportunity to Lead uniQure N.V. Securities Fraud Lawsuit with the Schall Law Firm

uniQure N.V. Securities Fraud Class Action Result of FDA Approval Delay and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

ROSEN, A LEADING NATIONAL FIRM, Encourages uniQure N.V. Investors to Secure Counsel Before Important Deadline in Securities Class Action - QURE

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of April 13, 2026 in uniQure N.V. Lawsuit – QURE